Lynn Singer, PhD

Professor, Departments of Population and Quantitative Health Sciences, Pediatrics, Psychiatry and Psychology | 216.368.1610 | Wood Bldg. WG-49G



• PhD, Clinical Psychology, Case Western Reserve University, 1979
• MA, Psychology, Case Western Reserve University, 1978
• MEd, Learning and Behavior Disorders, University of Pittsburgh, 1970
• BA, French/Psychology, Duquesne University, 1969

Research Interests

Dr. Singer has directed a number of large, federally and privately funded research programs, including: a 19-year study of high-risk, preterm infants with lung disease and their families; a longitudinal study of cocaine-exposed infants; and a birth cohort study of MDMA exposure. She has edited two books, Psychosocial Assessment of Adolescents and Biobehavioral Assessment of Infants, and authored more than 150 articles in medical and psychological literature. In 1997, the Case Western Reserve School of Medicine named her a “Million Dollar Professor.” She recently was named a CWRU Distinguished Professor, a recognition for her contributions to education and research over her long career at Case Western Reserve University.

Contributions to science:
• Influences on the outcomes of high-risk infants
• Developmental neurotoxicology
• Led the only studies worldwide to investigate effects of 3.4-methylenedioxymethamphetamine during pregnancy
• Collaborated in and/or led studies of infant development over more than 30 years

Recent Publications

  1. Singer, L. Response letter to Qiu et al. Drug Alcohol Depend 2020; 206 : 107777. PubMed PMID:31813600 .
  2. Larson, JJ, Graham, DL, Singer, LT, Beckwith, AM, Terplan, M, Davis, JM, Martinez, J, Bada, HS. Cognitive and Behavioral Impact on Children Exposed to Opioids During Pregnancy. Pediatrics 2019; 144 (2): . PubMed PMID:31320466 .
  3. Min, MO, Yoon, D, Minnes, S, Ridenour, T, Singer, LT. Profiles of individual assets and mental health symptoms in at-risk early adolescents. J Adolesc 2019; 75 : 1-11. PubMed PMID:31288121 PubMed Central PMC6699914.
  4. Min, MO, Minnes, S, Park, H, Ridenour, T, Kim, JY, Yoon, M, Singer, LT. Developmental trajectories of externalizing behavior from ages 4 to 12: Prenatal cocaine exposure and adolescent correlates. Drug Alcohol Depend 2018; 192 : 223-232. PubMed PMID:30273890 PubMed Central PMC6310164.
  5. Singer, LT, Min, MO, Minnes, S, Short, E, Lewis, B, Lang, A, Wu, M. Prenatal and concurrent cocaine, alcohol, marijuana, and tobacco effects on adolescent cognition and attention. Drug Alcohol Depend 2018; 191 : 37-44. PubMed PMID:30077054 .
  6. Min, MO, Minnes, S, Kim, JY, Yoon, M, Singer, LT. Individual assets and problem behaviors in at-risk adolescents: A longitudinal cross-lagged analysis. J Adolesc 2018; 64 : 52-61. PubMed PMID:29408099 PubMed Central PMC5857248.
  7. Lewis, BA, Minnes, S, Min, MO, Short, EJ, Wu, M, Lang, A, Weishampel, P, Singer, LT. Blood lead levels and longitudinal language outcomes in children from 4 to 12 years. J Commun Disord ; 71 : 85-96. PubMed PMID:29373108 PubMed Central PMC5801000.
  8. Min, MO, Minnes, S, Kim, JY, Yoon, M, Singer, LT. Association of prenatal cocaine exposure, childhood maltreatment, and responses to stress in adolescence. Drug Alcohol Depend 2017; 177 : 93-100. PubMed PMID:28582699 PubMed Central PMC5541909.
  9. Minnes, S, Min, MO, Kim, JY, Francis, MW, Lang, A, Wu, M, Singer, LT. The association of prenatal cocaine exposure, externalizing behavior and adolescent substance use. Drug Alcohol Depend 2017; 176 : 33-43. PubMed PMID:28514694 PubMed Central PMC5637277.
  10. Kilbride, HW, Aylward, GP, Doyle, LW, Singer, LT, Lantos, J. Prognostic neurodevelopmental testing of preterm infants: do we need to change the paradigm? J Perinatol 2017; 37 (5): 475-479. PubMed PMID:28252658 .
Search PubMed